Clinical Trials Logo

Health, Subjective clinical trials

View clinical trials related to Health, Subjective.

Filter by:

NCT ID: NCT05361876 Completed - Health, Subjective Clinical Trials

Thermographic Analysis of Hemodynamics Changes Through & Following Wingate Test

Start date: March 1, 2021
Phase:
Study type: Observational

Remote sensing and measurements of hemodynamic changes in blood flow for Wingate Anaerobic test using a novel image processing algorithm. The algorithm calculates the heat distribution from the thermal images and assesses the changes in blood flow and temperatures in the torso and legs for each individual participant.

NCT ID: NCT05252598 Withdrawn - Anxiety Clinical Trials

Mood and Cognitive Effects of Psilocybin in Healthy Participants

MELO
Start date: January 2023
Phase: Early Phase 1
Study type: Interventional

This study is seeking to find the optimal microdose or low dose of psilocybin (magic mushrooms) that provides general enhancements to mood, memory, sleep, and other measures of general well-being without any hallucinogenic effects.

NCT ID: NCT05236244 Completed - Health, Subjective Clinical Trials

Motor Imagery in Healthy Individuals

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The research will be the first to examine the relationship between mental fatigue induced by motor imagery and upper extremity performance. This study, it is aimed to examine whether the effects of mental fatigue created by motor imagery on upper extremity performance can be reduced by diaphragmatic breathing exercises.

NCT ID: NCT05232175 Completed - Health, Subjective Clinical Trials

Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer

Start date: January 18, 2022
Phase: Phase 1
Study type: Interventional

A Phase I Study to Evaluate the Tolerance, Safety and Pharmacokinetics of ALT-BB4 in Healthy Volunteers

NCT ID: NCT05214833 Recruiting - Health, Subjective Clinical Trials

Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback

NF-Agency
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

This study investigates whether the sense of agency is sensitive to self-regulation by means of EEG-based neurofeedback. During neurofeedback, the brain activity in response to a motor task is recorded in real-time and displayed back to the participants. The participants can therefore use this information to adapt their performance on the motor task.

NCT ID: NCT05182918 Completed - Clinical trials for Substance Use Disorders

Substance Use and Lifestyle-related Health Problems in Ageing Patients in OMT Treatment

AgeSUD
Start date: December 1, 2012
Phase:
Study type: Observational

The overall aim of the study is to explore substance use, tobacco use and lifestyle-related health problems among ageing patients in Opioid Maintenance Treatment (OMT), and other SUD treatment. The study will use already collected data from the multi-center, longitudinal, observational NorComt study (Norwegian Cohort of Patients in Opioid Maintenance Treatment and Other Drug Treatment study). NorComt is the largest longitudinal study of SUD patients in Norway. The data consists of data from OMT and other substance use disorders (SUD) treatment (N=548).

NCT ID: NCT05014958 Completed - Health, Subjective Clinical Trials

The Effect of Whole Body Vibration Training on Trunk Muscle Strength, Body Composition and Performance Parameters

Start date: May 17, 2021
Phase: N/A
Study type: Interventional

Whole body vibration (WBV) trainings are widely used in the field of sports medicine and rehabilitation. It is accepted that these trainings are a modality that can safely increase muscular activation and performance. However, although many exercise models have been tried on vibration platforms, a standard WBV program for trunk muscles has not been established. A total of 45 healthy individuals will be included in the study. Participants will be divided into 3 groups. Group 1 will perform exercises at 40hz frequency, group 2 will perform exercises at 25hz frequency on WBV. The control group will perform the same exercises at 0 Hz. The training will last 6 weeks and each session consists of 5 exercises.The training consists of basic core exercises that the individual does with his or her own body weight. Each training session is approximately 30 minutes. All participants will be evaluated using an isokinetic strength test with a Cybex dynamometer at the beginning and at the end of the additional treatment protocol. In addition, balance, body composition and anaerobic performance of individuals will be evaluated.

NCT ID: NCT05009368 Completed - Health, Subjective Clinical Trials

A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers

Start date: July 23, 2021
Phase: Phase 1
Study type: Interventional

This is a two-arm, open-label, single-sequence, multiple-dose, cross-over phase 1 study to evaluate the interaction between two investigational drugs by comparing and analyzing the pharmacokinetic interaction and safety of CTL0901 and CTL0902 at steady state when administered alone or in combination with repeated oral doses in healthy adult volunteers.

NCT ID: NCT05002634 Not yet recruiting - Health, Subjective Clinical Trials

Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer

Start date: August 5, 2021
Phase: N/A
Study type: Interventional

This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. Liver function test, renal function test, and adverse event will be assessed.

NCT ID: NCT05002244 Completed - Health, Subjective Clinical Trials

A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers

Start date: July 23, 2021
Phase: Phase 1
Study type: Interventional

This is a two-arm, open-label, single-sequence, multiple-dose, cross-over phase 1 study to evaluate the interaction between two investigational drugs by comparing and analyzing the pharmacokinetic interaction and safety of CTL0801 and CTL0802 at steady state when administered alone or in combination with repeated oral doses in healthy adult volunteers.